Institutions / Seven Fleet Capital Management LP / Holdings
Back to Seven Fleet Capital Management LP

Seven Fleet Capital Management LP

All holdings · as of Dec 31, 2025

85 positions

CompanyClassValueShares% of portfolio
Vir Biotechnology, Inc.—$1.2K2000.0%
ABIVAX SA—$1.6K120.0%
Eledon Pharmaceuticals, Inc.—$9.1K6,0000.0%
Beam Therapeutics Inc.—$9.3K3370.0%
GENERATION BIO CO—$30.5K5,3760.0%
Cullinan Therapeutics, Inc.—$31.1K3,0000.0%
ENANTA PHARMACEUTICALS INC—$35.8K2,2700.0%
Vistagen Therapeutics, Inc.VTGNCommon Stock$41.5K62,7010.0%
Edgewise Therapeutics, Inc.—$49.6K2,0000.0%
ASTRIA THERAPEUTICS INC—$52.4K4,0000.0%
Traws Pharma, Inc.—$55.7K49,2600.0%
Monte Rosa Therapeutics, Inc.—$62.7K4,0000.0%
PMV Pharmaceuticals, Inc.PMVPCommon Stock$79.4K63,4980.1%
Immunic, Inc.—$82.8K155,2230.1%
Trevi Therapeutics, Inc.—$89.0K7,1100.1%
REGENCELL BIOSCIENCE HLDGS L—$92.4K4,4000.1%
Verastem, Inc.—$116.9K15,1400.1%
ALX Oncology Holdings Inc.—$133.1K117,8170.1%
Apogee Therapeutics, Inc.—$135.9K1,8000.1%
Amylyx Pharmaceuticals, Inc.—$139.8K11,5710.1%
NEWAMSTERDAM PHARMA COMPANY—$140.3K4,0000.1%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$146.8K4,3150.1%
Oruka Therapeutics, Inc.—$158.8K5,2400.1%
Enliven Therapeutics, Inc.ELVNCommon Stock$180.0K11,6880.1%
Ocular Therapeutix, Inc—$207.6K17,1000.2%
CytomX Therapeutics, Inc.—$208.3K48,8980.2%
UNIQURE NV—$209.2K8,7420.2%
Viking Therapeutics Inc—$211.1K6,0000.2%
ENTERA BIO LTD—$262.5K135,3180.2%
COMPASS Pathways plcCMPSADR$276.0K40,0000.2%
Climb Bio, Inc.CLYMCommon Stock$305.6K76,4000.2%
Septerna, Inc.SEPNCommon Stock$319.1K11,4450.2%
Aclaris Therapeutics, Inc.—$323.3K107,4190.2%
PLIANT THERAPEUTICS, INC.PLRXCommon Stock$337.3K276,5000.3%
TARSUS PHARMACEUTICALS, INC.—$368.5K4,5000.3%
Savara IncSVRACommon Stock$378.5K62,7620.3%
Nurix Therapeutics, Inc.—$379.4K20,0000.3%
PROTHENA CORP PUBLIC LTD CO—$413.5K43,3000.3%
Viridian Therapeutics, Inc.—$456.0K14,6540.3%
Corbus Pharmaceuticals Holdings, Inc.CRBPCommon Stock$461.9K56,7500.4%
ZYMEWORKS INC.—$542.4K20,6000.4%
Evolus, Inc.—$545.3K82,0000.4%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$553.2K15,2430.4%
MBX Biosciences, Inc.MBXCommon Stock$574.0K18,2000.4%
Dianthus Therapeutics, Inc.—$603.8K14,6510.5%
Relay Therapeutics, Inc.—$617.6K73,0000.5%
United Therapeutics Corp—$633.4K130,0000.5%
NEKTAR THERAPEUTICS—$634.2K15,0000.5%
Cytokinetics Inc—$656.7K10,3350.5%
CIDARA THERAPEUTICS INC—$668.4K3,0260.5%
← PrevPage 1 of 2Next →